O'Connor Donal bought TBPH
June 12, 2026 · Form 4 insider transaction
O'Connor Donal bought 13,398 shares of Theravance Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,398
Price
$0.00
Total value
N/A
InsiderO'Connor Donal
RoleDirector
SecurityShare Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 12, 2026
Filing dateJune 16, 2026
Shares owned after13,398
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.